Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.54p
   
  • Change Today:
      0.013p
  • 52 Week High: 1.85p
  • 52 Week Low: 0.52p
  • Currency: UK Pounds
  • Shares Issued: 429.62m
  • Volume: 327,031
  • Market Cap: £2.31m
  • Beta: 0.89

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
56.26% below the market average56.26% below the market average56.26% below the market average56.26% below the market average56.26% below the market average
56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
26.66% above the market average26.66% above the market average26.66% above the market average26.66% above the market average26.66% above the market average
7.14% below the sector average7.14% below the sector average7.14% below the sector average7.14% below the sector average7.14% below the sector average
Price Book Ratio
5.24% above the market average5.24% above the market average5.24% above the market average5.24% above the market average5.24% above the market average
48.84% above the sector average48.84% above the sector average48.84% above the sector average48.84% above the sector average48.84% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
75.03% below the market average75.03% below the market average75.03% below the market average75.03% below the market average75.03% below the market average
56% below the sector average56% below the sector average56% below the sector average56% below the sector average56% below the sector average
Price Chg 3m
69.79% below the market average69.79% below the market average69.79% below the market average69.79% below the market average69.79% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
58.83% below the market average58.83% below the market average58.83% below the market average58.83% below the market average58.83% below the market average
82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average
Momentum 20
3.06% above the market average3.06% above the market average3.06% above the market average3.06% above the market average3.06% above the market average
Sector averageSector averageSector averageSector averageSector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
89.77% below the market average89.77% below the market average89.77% below the market average89.77% below the market average89.77% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
87.02% below the market average87.02% below the market average87.02% below the market average87.02% below the market average87.02% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average
Operating Profit Loss
65.97% below the market average65.97% below the market average65.97% below the market average65.97% below the market average65.97% below the market average
6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average6.12% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
65.7% below the market average65.7% below the market average65.7% below the market average65.7% below the market average65.7% below the market average
31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average
Cash
43.49% below the market average43.49% below the market average43.49% below the market average43.49% below the market average43.49% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
28.29% below the market average28.29% below the market average28.29% below the market average28.29% below the market average28.29% below the market average
46.15% below the sector average46.15% below the sector average46.15% below the sector average46.15% below the sector average46.15% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.54p
Change Today 0.013p
% Change 2.38 %
52 Week High 1.85p
52 Week Low 0.52p
Volume 327,031
Shares Issued 429.62m
Market Cap £2.31m
Beta 0.89

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.82% below the market average14.82% below the market average14.82% below the market average14.82% below the market average14.82% below the market average
72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average
Price Trend
86.02% below the market average86.02% below the market average86.02% below the market average86.02% below the market average86.02% below the market average
79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average
Income Not Available
Growth
17.33% below the market average17.33% below the market average17.33% below the market average17.33% below the market average17.33% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average

Theracryf Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
11:22 3,369 @ 0.52p
10:04 210,000 @ 0.53p
08:33 100,000 @ 0.55p
08:31 13,662 @ 0.55p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page